<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The following bacterial and fungal strains were used in the study:
 <italic class="italic"> Klebsiella pneumoniae</italic> (ATCC 13883 and clinical isolate),
 <italic class="italic"> Pseudomonas aeruginosa </italic>(ATCC 27853 and clinical isolate),
 <italic class="italic"> Staphylococcus aureus</italic> (ATCC 25923 and clinical isolate),
 <italic class="italic"> Streptococcus pyogen</italic> (ATCC 19615 and clinical isolate),
 <italic class="italic"> Aspergillus niger</italic> (ATCC 10535 and clinical isolate),
 <italic class="italic"> Candida albicans</italic> (clinical isolates),
 <italic class="italic"> Microsporum canis </italic>(clinical isolate),
 <italic class="italic"> Trichophyton mentagrophytes </italic>(ATCC 18748 and clinical isolate)
 <italic class="italic">, Trichophyton rubrum</italic> (ATCC28188), and
 <italic class="italic"> Trichophyton verrucosum </italic>(clinical isolate). The clinical isolates of the test organisms were obtained from Bacteriology and Mycology Directorate, EPHI.
</p>
